Co-beneldopa (Benserazide/levodopa) vs Rasagiline mesilate
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 5.1× as often as Rasagiline mesilate in May 2026 — 77,476 items versus 15,188 in England.
77,476items
Co-beneldopa (Benserazide/levodopa) · May 2026
NHSBSA Prescription Cost Analysis
15,188items
Rasagiline mesilate · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Co-beneldopa (Benserazide/levodopa) versus Rasagiline mesilate: national items dispensed by month
▬ Co-beneldopa (Benserazide/levodopa) · ╌ Rasagiline mesilate
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Co-beneldopa (Benserazide/levodopa) | Rasagiline mesilate |
|---|---|---|
| Items, May 2026 | 77,476 | 15,188 |
| Items, last 12 months | 948,791 | 188,114 |
| Net ingredient cost, May 2026 | £953,642 | £39,698 |
See the full profile for Co-beneldopa (Benserazide/levodopa) or Rasagiline mesilate.